INHL - Inhale Therapeutics - Pulmonary Insulin! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : INHL - Inhale Therapeutics - Pulmonary Insulin!

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: deeno who wrote (213)	2/23/2005 3:46:46 PM
From: deeno	Read Replies (1) of 225

long time no hear from the other 62 people that have this bookmarked. Though I gave up awhile ago, saw this from morgan stanley for Pfizer. In case anyone was waiting for an update. Mid 2007 - launch It may happen, who knows but between the insider selling, dilution, filing in euro first, delays on fda filing and emphasis away from "inhale" I'm glad I got out. Good luck to the rest. edited for brevity Additional Spending Required to Support New Products New Products expected launch Lyrica mid-2005 macugen launched Indiplon mid-2006 Exubera mid-2007 Asenapine 2006 Oporia mid-2005 Roflumilast 2006 Capravirine 2006 Varenicline 2007 Torcetrapib 2008 Total 240 660 825 1400 Change in Promotional Spending (282) (536) (890) (918) Change in Taxes 62 118 196 202 Net Income Benefit 220 418 694 716 share count 7,614 7,505 7,382 7,259 EPS Impact 0.03 $ 0.06 $ 0.09 $ 0.10 $ Current estimates 2.10 $ 2.18 $ 2.13 $ 2.29 $ % change 1.4% 2.6% 4.4% 4.3% Source: Morgan Stanley Research Estimates.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next